Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
Francisco R Stefanini,1–3 Maurício Maia,1 Paulo Falabella,1–3 Marcel Pfister,2,3 Moritz Niemeyer,2 Amir H Kashani,3 Mark S Humayun,3 Michael J Koss2,3,41Retina Division, Department of Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, Brazi...
Guardado en:
Autores principales: | Stefanini FR, Maia M, Falabella P, Pfister M, Niemeyer M, Kashani AH, Humayun MS, Koss MJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad39e17d92fb45198ed107c387ba6ae9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman S, et al.
Publicado: (2020) -
Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review
por: Schneider EW, et al.
Publicado: (2011) -
Retinal breaks due to intravitreal ocriplasmin
por: Silva RA, et al.
Publicado: (2014) -
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
por: Reichel E, et al.
Publicado: (2016) -
Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock M, et al.
Publicado: (2015)